Platform
Consulting
Resources
Pricing
Team Grant: ERDERA Joint Transnational Call 2026
Open

Team Grant: ERDERA Joint Transnational Call 2026

International rare disease research funding
Last Update: April 21, 2026
Funding available
$ 450,000
Timeline
  • Closing date : July 8, 2026
Location
Canada

Overview

This program supports international research on unresolved rare genetic and non-genetic diseases. The maximum funding is CAD 450,000 per grant for up to 3 years, and eligible activities include collaborative diagnostic research, data analysis, and related project work.
/100
Opportunity Score
Moderate potential, but conditions must align.

At a glance

Funding available

Financing goals
  • Develop strategic partnerships
  • Develop team skills
  • Increase social or community impact
Eligible Funding
  • Maximum amount : 450,000 $
Timeline
  • Closing date : July 8, 2026

Eligible candidates

Eligible Industries
  • Professional, scientific and technical services
  • Health care and social assistance
Location
  • Canada
Legal structures
  • All legal structures
Annual revenue
  • All revenue ranges
Organisation size
  • All organization sizes
Audience
  • All groups

Next Steps

1
Determine your project
2
Validate your eligibility

Activities funded

  • Diagnostic research on unresolved rare genetic diseases
  • Research on complex rare non-genetic diseases
  • Identification of causative variants in undiagnosed cases
  • Use of multi-omics, bioinformatics, AI, and systems biology approaches

Documents Needed

  • CVs for participants, except collaborators
  • Research proposal summary
  • Budget information and justification
  • Attestation form for sensitive technology research, if applicable
  • Signed proposal signature pages and routing slip

Eligibility

Who is eligible?

  • Universities and research institutes
  • Hospitals and public health institutions
  • Private companies
  • Patient advocacy organisations

Who is not eligible

  • Groups outside the participating countries
  • Applicants under excluded national rules
  • PAOs where national rules do not allow funding
  • Organizations listed as ineligible by a national funder

Eligible expenses

  • Personnel costs for project work
  • Consumables and materials
  • Travel and meeting costs
  • Equipment and minor equipment
  • Data management and consultancy services

Ineligible Costs and Activities

  • Pre-clinical therapy development studies
  • Interventional clinical trials
  • Projects focused only on excluded rare neurodegenerative diseases
  • Rare infectious diseases and rare cancers
  • Overheads for CIHR funding

Eligible geographic areas

  • Canada
  • Austria
  • Belgium
  • Bulgaria
  • Czech Republic
  • Cyprus
  • Denmark
  • Estonia
  • France
  • Germany
  • Hungary
  • Ireland
  • Israel
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden
  • The Netherlands
  • Türkiye

Processing and Agreement

  • Applications are checked for formal and national eligibility.
  • Eligible pre-proposals are reviewed and ranked by expert reviewers.
  • Only invited applicants may submit a full proposal.
  • Full proposals undergo scientific and ethics review before funding decisions.
  • Applicants are notified of the final decision and funded projects are published.

Additional information

  • Funding is awarded through a two-stage transnational process.
  • All funded partners must sign a consortium agreement.
  • Open access is required for peer-reviewed publications.
  • Annual and final reporting obligations apply.

Contacts

Frequently Asked Questions about the Team Grant: ERDERA Joint Transnational Call 2026 Program

Here are answers to the most common questions about the Team Grant: ERDERA Joint Transnational Call 2026. This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.

What is the Team Grant: ERDERA Joint Transnational Call 2026?

This program supports international research on unresolved rare genetic and non-genetic diseases. The maximum funding is CAD 450,000 per grant for up to 3 years, and eligible activities include collaborative diagnostic research, data analysis, and related project work.

How much funding can be received?

Team Grant: ERDERA Joint Transnational Call 2026 Funds up to $450,000 of admissible expenses.

Who is eligible for the Team Grant: ERDERA Joint Transnational Call 2026 program?

To be eligible for the Team Grant: ERDERA Joint Transnational Call 2026 program, you must: Independent Canadian lead researcher Eligible Canadian host institution Project must fit call scope

What expenses are eligible under Team Grant: ERDERA Joint Transnational Call 2026?

Diagnostic research on unresolved rare genetic diseases Research on complex rare non-genetic diseases Identification of causative variants in undiagnosed cases Use of multi-omics, bioinformatics, AI, and systems biology approaches

Who can I contact for more information about the Team Grant: ERDERA Joint Transnational Call 2026?

You can contact Canadian Institutes of Health Research (CIHR) by email at ERDERAcall@agencerecherche.fr or by phone at 613-954-1968.

Where is the Team Grant: ERDERA Joint Transnational Call 2026 available?

The Team Grant: ERDERA Joint Transnational Call 2026 program is available across Canada.

Is the Team Grant: ERDERA Joint Transnational Call 2026 a grant, loan, or tax credit?

Team Grant: ERDERA Joint Transnational Call 2026 is a Partnering and Collaboration